These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 25488879)

  • 1. Cost-value analysis of health interventions: introduction and update on methods and preference data.
    Nord E
    Pharmacoeconomics; 2015 Feb; 33(2):89-95. PubMed ID: 25488879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concerns for severity in priority setting in health care: a review of trade-off data in preference studies and implications for societal willingness to pay for a QALY.
    Nord E; Johansen R
    Health Policy; 2014 Jun; 116(2-3):281-8. PubMed ID: 24690334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards cost-value analysis in health care?
    Nord E
    Health Care Anal; 1999; 7(2):167-75. PubMed ID: 15968970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Societal Preferences for Interventions with the Same Efficiency: Assessment and Application to Decision Making.
    Shiroiwa T; Saito S; Shimozuma K; Kodama S; Noto S; Fukuda T
    Appl Health Econ Health Policy; 2016 Jun; 14(3):375-85. PubMed ID: 26940671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the value of treating schizophrenia?
    Carr VJ; Lewin TJ; Neil AL
    Aust N Z J Psychiatry; 2006; 40(11-12):963-71. PubMed ID: 17054564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-Value Analysis and the SAVE: A Work in Progress, But an Option for Localised Decision Making?
    Karnon J; Partington A
    Pharmacoeconomics; 2015 Dec; 33(12):1281-8. PubMed ID: 26100285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valuing QALYs in Relation to Equity Considerations Using a Discrete Choice Experiment.
    van de Wetering L; van Exel J; Bobinac A; Brouwer WB
    Pharmacoeconomics; 2015 Dec; 33(12):1289-300. PubMed ID: 26232199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness versus cost-utility analysis of interventions for cancer: does adjusting for health-related quality of life really matter?
    Tengs TO
    Value Health; 2004; 7(1):70-8. PubMed ID: 14720132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Willingness to pay for a quality-adjusted life year: implications for societal health care resource allocation.
    King JT; Tsevat J; Lave JR; Roberts MS
    Med Decis Making; 2005; 25(6):667-77. PubMed ID: 16282217
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Willingness to Pay for Health-Related Quality of Life Gains in Relation to Disease Severity and the Age of Patients.
    Reckers-Droog V; van Exel J; Brouwer W
    Value Health; 2021 Aug; 24(8):1182-1192. PubMed ID: 34372984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beyond QALYs: Multi-criteria based estimation of maximum willingness to pay for health technologies.
    Nord E
    Eur J Health Econ; 2018 Mar; 19(2):267-275. PubMed ID: 28258399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Economic examination of the 2006/7 update of the Israeli national list of health services].
    Shmueli A; Nissan-Englcin E
    Harefuah; 2008 Jun; 147(6):488-92, 576. PubMed ID: 18693622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incorporating societal concerns for fairness in numerical valuations of health programmes.
    Nord E; Pinto JL; Richardson J; Menzel P; Ubel P
    Health Econ; 1999 Feb; 8(1):25-39. PubMed ID: 10082141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A utility-theoretic model for QALYs and willingness to pay.
    Klose T
    Health Econ; 2003 Jan; 12(1):17-31. PubMed ID: 12483758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Economic evaluation in health care].
    Zechmeister I; Radlberger P
    Wien Med Wochenschr; 2009; 159(5-6):160-8. PubMed ID: 19343294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The monetary value of a life year: evidence from a qualitative study of treatment costs.
    McKie J; Shrimpton B; Richardson J; Hurworth R
    Health Econ; 2011 Aug; 20(8):945-57. PubMed ID: 20806424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic evaluation in cardiology.
    Maniadakis N; Vardas P; Mantovani LG; Fattore G; Boriani G
    Europace; 2011 May; 13 Suppl 2():ii3-8. PubMed ID: 21518746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Societal value of stem cell therapy in stroke--a modeling study.
    Svensson J; Ghatnekar O; Lindgren A; Lindvall O; Norrving B; Persson U; Kokaia Z
    Cerebrovasc Dis; 2012; 33(6):532-9. PubMed ID: 22571941
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.